NCT00086294View on ClinicalTrials.gov

ACP-103 to Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 25, 2004

Study Completion Date

November 15, 2007

Conditions
Parkinson's DiseaseDyskinesias
Interventions
DRUG

Intravenous Levodopa

DRUG

ACP-103

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00086294 - ACP-103 to Treat Parkinson's Disease | Biotech Hunter | Biotech Hunter